Long-term Vision and Neurodevelopmental Outcomes in Laser and Bevacizumab-Treated Infants with Retinopathy of Prematurity

被引：0
|
作者：
Li, Alexa L. [1 ]
Rahman, Effie Zhu [1 ]
Voigt, Robert G. [1 ]
Coats, David K. [1 ]
Steinkuller, Paul G. [1 ]
Kong, Lingkun [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4321
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long-term retinal vasculature abnormalities following intravitreal bevacizumab for retinopathy of prematurity
    Amir Sternfeld
    Safa Rahmani
    Jennifer L. Rossen
    David L. Zhang
    Yuping D. Li
    Victor L. Quan
    Russell Huang
    Hawke H. Yoon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 1915 - 1921
  • [42] Argon laser photocoagulation for retinopathy of prematurity: long-term outcome
    Ospina, LH
    Lyons, CJ
    Matsuba, C
    Jan, J
    McCormick, AQ
    EYE, 2005, 19 (11) : 1213 - 1218
  • [43] Outcomes in Type I Retinopathy of Prematurity treated with intravitreal bevacizumab
    Mallick, Adnan
    Savoie, Brian
    Lieberman, Ronni M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [44] Outcomes In Type I Retinopathy of Prematurity Treated with Intravitreal Bevacizumab
    Savoie, Brian
    Mallick, Adnan
    Lieberman, Ronni M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [45] Long-term Neurodevelopmental Outcomes in Preterm Infants with Posthemorrhagic Hydrocephalus Treated with Temporizing Devices
    Bernhardt, Lydia
    Leppert, Mary
    Cristofalo, Elizabeth
    Ahn, Edward
    NEUROLOGY, 2018, 90
  • [46] Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity A Meta-analysis
    Tsai, Chia-Ying
    Yeh, Po-Ting
    Tsao, Po-Nien
    Chung, Yu-Chu Ella
    Chang, Yu-Shan
    Lai, Tso-Ting
    OPHTHALMOLOGY, 2021, 128 (06) : 877 - 888
  • [47] Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity
    Zhang, David L.
    Yoon, Hawke H.
    deRegnier, Raye-Ann O.
    Arzu, Jennifer
    Rahmani, Safa
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 2713 - 2722
  • [48] Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity
    Araz-Ersan, Bilge
    Kir, Nur
    Tuncer, Samuray
    Aydinoglu-Candan, Ozlem
    Yildiz-Inec, Dilbade
    Akdogan, Basri
    Ekici, Baris
    Demirel, Atalay
    Ozmen, Meral
    CURRENT EYE RESEARCH, 2015, 40 (06) : 585 - 591
  • [49] Risk factor analysis for long-term unfavorable ocular outcomes in children treated for retinopathy of prematurity
    Mutlu, Fatih Mehmet
    Kucukevcilioglu, Murat
    Ceylan, Osman Melih
    Altinsoy, Halil Ibrahim
    Sarici, S. Umit
    TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (01) : 35 - 41
  • [50] Long-Term Growth and Development in Bevacizumab-Treated Pediatric and Adolescent Patients: An Integrated Analysis
    Muller, H. L.
    Merks, J. H. M.
    Geoerger, B.
    Grill, J.
    Hargrave, D.
    Bender, J. Glade
    Gururangan, S.
    Navid, F.
    Johnston, M.
    Bachir, J.
    Hilton, M.
    Furst-Recktenwald, S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S343 - S344
12345